Cellebrite DI Ltd. (CLBT) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
CLBT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CLBT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 84.2% | 14.0% | 16.5% |
| 2024 | 84.4% | 14.2% | -70.5% |
| 2023 | 83.6% | 10.2% | -24.9% |
| 2022 | 81.3% | 0.4% | 44.6% |
| 2021 | 82.7% | 5.6% | 29.0% |
Download Data
Export CLBT earnings history in CSV or JSON format
Free sign-in required to download data
Cellebrite DI Ltd. (CLBT) Earnings Overview
As of May 8, 2026, Cellebrite DI Ltd. (CLBT) reported trailing twelve-month net income of $78M, reflecting +123.0% year-over-year growth. The company earned $0.31 per diluted share over the past four quarters, with a net profit margin of 16.5%.
Looking at the long-term picture, CLBT's 5-year EPS compound annual growth rate (CAGR) stands at +58.6%, indicating exceptional earnings growth. The company achieved its highest annual net income of $121M in fiscal 2022.
Cellebrite DI Ltd. maintains industry-leading profitability with a gross margin of 84.2%, operating margin of 14.0%, and net margin of 16.5%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including AXON ($206M net income, 4.5% margin), VRNS (-$137M net income, -20.7% margin), OSPN ($70M net income, 30.0% margin), CLBT has outperformed on profitability metrics. Compare CLBT vs AXON →
CLBT Earnings vs Peers
Earnings metrics vs comparable public companies
CLBT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +127.7% | $66M | $0.31 | 16.5% | 14.0% |
| 2024 | -$283M | -249.0% | $57M | $-1.35 | -70.5% | 14.2% |
| 2023 | -$81M | -167.1% | $33M | $-0.43 | -24.9% | 10.2% |
| 2022 | $121M | +69.2% | $1M | $0.59 | 44.6% | 0.4% |
| 2021 | $71M | +1135.0% | $14M | $0.44 | 29.0% | 5.6% |
| 2020 | $6M | +408.2% | $9M | $0.03 | 3.0% | 4.7% |
| 2019 | -$2M | - | -$2M | $-0.01 | -1.1% | -0.9% |
See CLBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLBT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLBT vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonCLBT — Frequently Asked Questions
Quick answers to the most common questions about buying CLBT stock.
Is CLBT growing earnings?
CLBT EPS is $0.31, with earnings growth accelerating to +123.0%. This exceeds the 5-year CAGR of +58.6%. TTM net income reached $78M.
What are CLBT's profit margins?
Cellebrite DI Ltd. net margin is +16.5%, with operating margin at +14.0%. Above-average margins indicate pricing power.
How consistent are CLBT's earnings?
CLBT earnings data spans 2019-2025. The accelerating earnings trend is +123.0% YoY. Historical data enables comparison across business cycles.